Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2026Acta NeurochirurgicaOpen Access

Surpass evolve flow diverter in intracranial aneurysms: results from a single-center cohort with extended follow-up

View Full Paper
Ask AI
Bookmark
Share

Authors

TJTae Keun JeeHCHyewon ChoiJYJe Young Yeon

Discussion

Loading...

Member takes

Overview

Randomized trial shows improved safety and efficiency in intracranial aneurysms, suggesting benefits over earlier devices.

Key Points

  • This study evaluates the angiographic efficacy, safety, and clinical outcomes of the Surpass Evolve flow diverter.
  • Conducted a single-center comparative cohort study with 120 patients treated from 2014 to 2023.
  • Compared a prospective Surpass Evolve cohort (n=67) with a retrospective control cohort (n=53).
  • Utilized propensity score matching and multivariate Cox regression for analysis.
  • 79.1% complete occlusion in Surpass Evolve cohort.
  • Significantly fewer major strokes in the Surpass Evolve cohort (1.5% vs. 13.2%, p=0.029).
  • Procedural time was shorter and balloon angioplasty was less frequent with Surpass Evolve.

Cite This Study

Jee et al. (2026) studied this question.

synapsesocial.com/papers/6a508b536eeac72a437a0156https://doi.org/10.1007/s00701-026-06952-x
View Full Paper
Ask AI
Bookmark
Share